This is a past event
Using primary care data and linkages to explore the effect of commonly used drugs on cancer incidence and progression - Professor Liam Murray, Queens University Belfast.
Liam Murray is Acting Director of the Centre for Public Health, Queen’s University Belfast. He is a clinical academic who trained in General Practice and Public Health, in Northern Ireland, Scotland and England. He leads the QUB Cancer Epidemiology and Health Services Research Group, which is a multidisciplinary research group that undertakes research into the aetiology and progression of cancer/premalignant disease and cancer health services research, including early detection and survivorship research.
Professor Murray has a particular interest in cancers of the gastro-intestinal tract, especially oesophageal adenocarcinoma, and he is PI of an all-Ireland case-control study of oesophageal adenocarcinoma (the finbar study) and the Northern Ireland Barrett’s Register. He also has a major interest in pharmaco-epidemiological studies in the cancer field with a focus on the impact of commonly prescribed medications on cancer incidence and progression and has recently published in this field using data from the UK Clinical Practice Research Datalink and the English National Cancer Data Repository.
Together with molecular pathologists, he is in the process of establishing unique tissue and databanks that will enable studies to be undertaken that explore modifiable risk factors for cancer development/progression on a population basis stratified by tumour molecular characteristics/profiles.
He has more than 200 publications in international scientific journals including in JAMA, BMJ, Journal of the National Cancer Institute (JNCI), Gastroenterology etc.
- Hosted by
- IAHS
- Venue
- Med-Chi Hall, Polwarth Building